This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS) | MicrobiomeTrials
← Back to trials NCT06351592
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS) Recruiting PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-08-28Est. Completion: 2032-03-21
Enrollment target: 54 participantsLocations Concord Repatriation General Hospital, Concord, New South Wales, Australia Macquarie University, Sydney, New South Wales, Australia Sunshine Coast University Hospital, Birtinya, Queensland, Australia KU Leuven, Leuven, Vlaams-Brabant, Belgium University of Alberta Hospital, Edmonton, Division of Neurology, Edmonton, Alberta, Canada University Hospital - London Health Sciences Centre, London, Ontario, Canada Sunnybrook Research Institute, Toronto, Ontario, Canada Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada Universitaetsklinikum Ulm AoR, Ulm, Baden-Wurttemberg, Germany Hokkaido University Hospital, Sapporo, Hokkaido, Japan Tokushima University Hospital, Tokushima, Tokushima, Japan Toho University Omori Medical Center, Ōta-ku, Tokyo, Japan Kyoto University Hospital, Kyoto, Japan Szpital Uniwersytecki w Krakowie, Oddzial Kliniczny Neurologii, Krakow, Lesser Poland Voivodeship, Poland Medical University of Silesia, Zabrze, Silesian Voivodeship, Poland MTZ Clinical Research powered by Pratia, Warsaw, Poland Other microbiome trials you might be interested in Amyotrophic Lateral Sclerosis
Eligible subjects will receive either different dosages of HK-001 or placebo in a 3:1 ratio in 1 of the 7 dose cohorts. …
Hualien City, Taiwan Est. completion Dec 31, 2027
Healthy
The purpose of this study is to assess the safety, tolerability and pharmacokinetics (i.e. how study drug is taken up by…
Multiple Locations Est. completion Mar 31, 2029
Hanyang University Seoul Hospital, Seoul, South Korea
Seoul National University Hospital, Seoul, South Korea
Noorlands University Hospital-Department of Neurology, Umeå, Noorland, Sweden
Karolinska University Hospital, Karolinska Institutet-ALS Center-Department of Clinical Neuroscience, Huddinge, Stockholm County, Sweden
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
Taipei Veterans General Hospital, Taipei, Taiwan